Tyler Bussian
Stock Analyst at Brookline Capital
(0)
# 4892
Out of 5,218 analysts
5
Total ratings
0.00%
Success rate
-29.53%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Envoy Medical | Initiates Coverage On: Buy | 9 | 1.99 | 352.26% | 1 | Oct 14, 2024 | |
CervoMed | Initiates Coverage On: Buy | 63 | 1.91 | 3198.43% | 1 | Jul 8, 2024 | |
Immunic | Initiates Coverage On: Buy | 10 | 1.13 | 784.96% | 1 | Apr 5, 2024 | |
Annovis Bio | Downgrades: Hold | 9 | 5.26 | 71.1% | 2 | Feb 28, 2024 |